Gene · 5170
Papers2,673
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,673
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways. | J Exp Clin Cancer Res | 2023 | 38087324 | PubTator, text mining | PubMed |
| Z-Ligustilide Combined with Cisplatin Reduces PLPP1-Mediated Phospholipid Synthesis to Impair Cisplatin Resistance in Lung Cancer. | Int J Mol Sci | 2023 | 38069368 | PubTator, text mining | PubMed |
| Unlocking New Avenues in Breast Cancer Treatment: The Synergy of Kinase Inhibitors and Immunotherapy. | Cancers (Basel) | 2023 | 38067203 | PubTator, text mining | PubMed |
| miR-423 sponged by lncRNA NORHA inhibits granulosa cell apoptosis. | J Anim Sci Biotechnol | 2023 | 38053184 | PubTator, text mining | PubMed |
| Uncoupling p38α nuclear and cytoplasmic functions and identification of two p38α phosphorylation sites on β-catenin: implications for the Wnt signaling pathway in CRC models. | Cell Biosci | 2023 | 38041178 | PubTator, text mining | PubMed |
| Emerging role and therapeutic implications of p53 in intervertebral disc degeneration. | Cell Death Discov | 2023 | 38040675 | PubTator, text mining | PubMed |
| Transcriptomics analyses reveal the effects of Pentagamaboronon-0-ol on PI3K/Akt and cell cycle of HER2+ breast cancer cells. | Saudi Pharm J | 2023 | 38028209 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Sis2 regulates yeast replicative lifespan in a dose-dependent manner. | Nat Commun | 2023 | 38012152 | PubTator, text mining | PubMed |
| Dependency of B-Cell Acute Lymphoblastic Leukemia and Multiple Myeloma Cell Lines on MEN1 Extends beyond MEN1-KMT2A Interaction. | Int J Mol Sci | 2023 | 38003662 | PubTator, text mining | PubMed |
| The Role of Exosome-Derived microRNA on Lung Cancer Metastasis Progression. | Biomolecules | 2023 | 38002256 | PubTator, text mining | PubMed |
| Age Is Just a Number: Progress and Obstacles in the Discovery of New Candidate Drugs for Sarcopenia. | Cells | 2023 | 37998343 | PubTator, text mining | PubMed |
| The Multifunctional Nature of the MicroRNA/AKT3 Regulatory Axis in Human Cancers. | Cells | 2023 | 37998329 | PubTator, text mining | PubMed |
| Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers. | Biomark Res | 2023 | 37981718 | PubTator, text mining | PubMed |
| Construction of an anoikis-associated lncRNA-miRNA-mRNA network reveals the prognostic role of β-elemene in non-small cell lung cancer. | Sci Rep | 2023 | 37980372 | PubTator, text mining | PubMed |
| Exosomes Interactions with the Blood-Brain Barrier: Implications for Cerebral Disorders and Therapeutics. | Int J Mol Sci | 2023 | 37958619 | PubTator, text mining | PubMed |
| MiR-1299 is regulated by KCNQ1OT1 and inhibits cervical cancer progression. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37953567 | PubTator, text mining | PubMed |
| Effect of FTY720P on lipid accumulation in HEPG2 cells. | Sci Rep | 2023 | 37953311 | PubTator, text mining | PubMed |
| Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy. | Signal Transduct Target Ther | 2023 | 37926722 | PubTator, text mining | PubMed |
| Structure and Function of a Class III Metal-Independent Lanthipeptide Synthetase. | ACS Cent Sci | 2023 | 37901177 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5170/papers?page=7